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Abstract
Extranodal marginal zone lymphomas of mucosa-associated lymphoid tissue (MALT) are associated
with various infectious pathogens. We analyzed the presence of Chlamydia psittaci, Chlamydia
pneumoniae, and Chlamydia trachomatis DNA in 47 nongastrointestinal and 14 gastrointestinal MALT
lymphomas, 37 nonmalignant control samples, and 27 autoimmune precursor lesions by polymerase
chain reaction amplification and direct sequencing. In 47 nongastrointestinal MALT lymphomas, 13
(28%) were positive for C psittaci DNA compared with 4 (11%) of 37 nonmalignant control samples (P
= .09). C psittaci was detected at variable frequencies in MALT lymphomas of different sites: lung,
100% (5/5; P < .01); thyroid gland, 30% (3/10; P > .05); salivary gland, 13% (2/15; P > .05); ocular
adnexa, 15% (2/13); and skin, 25% (1/4). Of 27 autoimmune precursor lesions (11 Hashimoto
thyroiditis and 16 Sjögren syndrome), 11 (41%) contained C psittaci DNA. Only 1 (7%) of 14
gastrointestinal MALT lymphomas was positive for C psittaci. All specimens were negative for C
trachomatis and C pneumoniae. Besides ocular adnexal lymphomas, C psittaci infection is associated
with nongastrointestinal MALT lymphomas and autoimmune precursor lesions, suggesting possible
involvement of C psittaci-induced antigenic-driven MALT lymphomagenesis.
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A b s t r a c t
Extranodal marginal zone lymphomas of mucosa-
associated lymphoid tissue (MALT) are associated with 
various infectious pathogens. We analyzed the presence 
of Chlamydia psittaci, Chlamydia pneumoniae, and 
Chlamydia trachomatis DNA in 47 nongastrointestinal 
and 14 gastrointestinal MALT lymphomas, 37 
nonmalignant control samples, and 27 autoimmune 
precursor lesions by polymerase chain reaction 
amplification and direct sequencing.
In 47 nongastrointestinal MALT lymphomas, 13 
(28%) were positive for C psittaci DNA compared 
with 4 (11%) of 37 nonmalignant control samples (P 
= .09). C psittaci was detected at variable frequencies 
in MALT lymphomas of different sites: lung, 100% 
(5/5; P < .01); thyroid gland, 30% (3/10; P > .05); 
salivary gland, 13% (2/15; P > .05); ocular adnexa, 
15% (2/13); and skin, 25% (1/4). Of 27 autoimmune 
precursor lesions (11 Hashimoto thyroiditis and 16 
Sjögren syndrome), 11 (41%) contained C psittaci 
DNA. Only 1 (7%) of 14 gastrointestinal MALT 
lymphomas was positive for C psittaci. All specimens 
were negative for C trachomatis and C pneumoniae.
Besides ocular adnexal lymphomas, C psittaci 
infection is associated with nongastrointestinal MALT 
lymphomas and autoimmune precursor lesions, 
suggesting possible involvement of C psittaci–induced 
antigenic-driven MALT lymphomagenesis.
Extranodal marginal zone (MZ) B-cell lymphomas of 
mucosa-associated lymphoid tissue (MALT lymphomas) are 
the second most common indolent lymphomas among all non-
Hodgkin lymphomas, originating from B cells of the MZ of 
MALT.1,2 There is clear evidence that MZ lymphomagenesis 
is closely associated with chronic antigenic stimulation by 
microbial pathogens or autoantigens.3
The list of pathogens associated with MZ lympho-
proliferations has grown longer and currently includes at 
least 5 members: Helicobacter pylori, Campylobacter jejuni, 
Borrelia burgdorferi, Chlamydia psittaci, and hepatitis C 
virus. These pathogens have been associated with MZ-derived 
gastric lymphoma, immunoproliferative small intestinal dis-
ease, cutaneous lymphoma, ocular adnexal lymphoma, and 
spleen lymphoma.3
The most common site of MALT lymphomas is the 
gastrointestinal tract, especially the stomach, where they are 
closely linked to H pylori–induced chronic gastritis, but virtu-
ally every organ can be affected.2,4 Because most of the organs 
in which MALT lymphomas develop lack lymphoid tissue, 
MALT acquisition following chronic antigenic stimulation is 
a prerequisite for lymphomagenesis.5 The best characterized 
model of “indirect lymphomagenesis” involving sustained 
stimulation of the immune system leading to lymphoid trans-
formation is the H pylori–associated MALT lymphoma of the 
stomach.1,4 H pylori eradication leads to complete regression of 
MALT lymphoma in early stages of disease, demonstrating a 
continuous dependency on chronic antigen stimulation.
Similar to chronic infection with H pylori, other patho-
gens have been reported to be associated with the develop-
ment of MALT lymphomas at nongastrointestinal sites, 
although the causative role is less well established.3,6,7 C psittaci 
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was identified as the causative infectious agent of ocular ad-
nexal MALT lymphomas.8-12 C psittaci was detected in up 
to 87% of ocular adnexal MALT lymphoma specimens, and 
a significant proportion of patients responded to doxycycline 
treatment.8,13,14 The strong association of C psittaci with ocu-
lar adnexal lymphomas, observed by Ferreri et al,8 could not 
be confirmed by other groups,15-17 suggesting evidence for 
geographic heterogeneity.18 There is also serologic evidence 
of an association between chronic chlamydial infection and 
non-Hodgkin lymphomas.19 Recently, C psittaci was detected 
in nodal and extranodal lymphomas, including different lym-
phoma entities and affecting localizations other than ocular 
adnexa.20 However, in that study, only a small number of non-
gastrointestinal MALT lymphomas other than ocular adnexal 
cases were included.
The aim of our study was, therefore, to investigate 
the presence of C psittaci, Chlamydia pneumoniae, and 
Chlamydia trachomatis DNA in a larger cohort of nongastro-
intestinal MALT lymphomas, nonmalignant control samples 
of the respective organs, and specimens from patients with 
Sjögren syndrome and with Hashimoto thyroiditis. As control 
samples from the gastrointestinal tract, gastric and intestinal 
MALT lymphomas and H pylori–positive gastritis were 
included. To determine the serum prevalence of C psittaci, 
serum samples of patients with nongastrointestinal MALT 
lymphomas and control serum samples from a standard hos-
pital population were analyzed.
Materials and Methods
Clinical Samples
A total of 47 MALT lymphomas were studied. Specimens 
were obtained from nongastrointestinal sites (lung, 5; thyroid 
gland, 10; salivary gland, 15; ocular adnexa, 13; and skin, 4). 
Normal lung tissue (n = 10), normal thyroid tissue (n = 13), 
normal salivary gland tissue (n = 7), and specimens obtained 
from patients with Sjögren syndrome (n = 16) and patients 
with Hashimoto thyroiditis (n = 11) were included as nonma-
lignant control samples. From the gastrointestinal tract, gastric 
MALT (n = 6), intestinal MALT (n = 8) lymphomas and H 
pylori–positive gastritis (n = 7) samples were included.
Lymphoma entities were classified according to the 
World Health Organization classification of lymphoid neo-
plasms.21 Macrodissected tissue containing more than 80% 
lymphoma cells from formalin-fixed, paraffin-embedded tis-
sue was processed for DNA isolation.
For the study, 14 serum samples from patients with non-
gastrointestinal MALT lymphomas were obtained from the 
serum collection of the Medical University of Vienna, Vienna, 
Austria. As control samples, 100 serum samples obtained from 
100 patients visiting the outpatient department of the Medial 
University of Graz, Graz, Austria, were analyzed.
All samples were analyzed in triplicate by C psittaci 
polymerase chain reaction (PCR) and positive cases directly 
sequenced as published previously.22 Real-time PCR was 
used for C trachomatis and C pneumoniae.
C psittaci PCR and DNA Sequencing
For detection of C psittaci, a PCR according to Madico et 
al22 was performed using identical primer sequences in single 
PCR reactions. The total volume of 40 !L of Master mixture 
contained 100 pmol of each primer, 0.25 mmol/L deoxy-
nucleoside triphosphates (dNTPs), PCR buffer containing 15 
mmol/L magnesium chloride, and 2 U of HotStarTaq DNA 
polymerase (Qiagen, Hilden, Germany). A touchdown method 
for thermal cycling was used according to Madico et al.22
PCR products were separated by electrophoresis in 2% 
agarose gels at 95 V for 30 minutes with 1× tris(hydroxymethyl)
aminomethane-acetate EDTA buffer and visualized with 
ethidium bromide (0.5 mg/mL). DNA fragments with the 
appropriate size of 111 base pairs were excised from the aga-
rose gel with a clean, sharp scalpel, and DNA was extracted 
with the QIAquick Gel Extraction Kit (Qiagen). In addition, 
a control PCR was performed using 100 pmol of the prim-
ers Pim1-1fw and Pim1/1-rev-a, 0.25 mmol/L dNTPs, PCR 
buffer containing 15 mmol/L magnesium chloride, and 0.75 
U of HotStarTaq DNA polymerase (Qiagen). To prove the 
origin of C psittaci, sequencing of 100 ng of the extracted 
samples was performed, according to the BigDye Terminator 
v1.1 Cycle Sequencing Kit protocol (Applied Biosystems, 
Foster City, CA) with primers CPS100 and CPS101. Products 
were purified by using ethanol precipitation, and samples 
were diluted in Hi-Di Formamide (Applied Biosystems). 
Sequencing was done with the ABI Prism 310 Genetic 
Analyzer (Applied Biosystems), and the results were evalu-
ated by BLAST search.
Real-Time PCR for Detection of C trachomatis and 
C pneumoniae DNA
As described by Aigelsreiter et al,9 a real-time PCR 
protocol was used for the detection of C pneumoniae DNA. 
The real-time PCR assay on the LightCycler 2.0 instrument 
(Roche Applied Science, Mannheim, Germany) was used as 
recently described.23 For the detection of C trachomatis DNA, 
a commercially available assay, the AMPLICOR Chlamydia 
trachomatis test (Roche Molecular Systems, Branchburg, NJ), 
was used according to the manufacturer’s instructions.
Immunohistochemical Studies for Detection of 
Chlamydial Antigen
If a sufficient amount of tissue (n = 24) was available, 
immunohistochemical analysis for C psittaci was performed. 
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Paraffin sections were studied for the presence of chlamydial 
antigen using a Chlamydiaceae family–specific mouse mono-
clonal antibody (Ab) directed against chlamydial lipopoly-
saccharide (clone ACI-P, Progen, Heidelberg, Germany). 
Detection was performed with the ChemMate Detection Kit 
(DAKO, Glostrup, Denmark) according to the manufacturer’s 
instructions. Briefly, paraffin sections were deparaffinized 
in xylene and rehydrated through graded ethanol to water. 
Antigen retrieval was performed by 10 minutes of enzyme 
digestion (Pronase, DAKO). To inhibit the endogenous 
peroxidase activity, the slides were immersed in peroxidase-
blocking solution for 5 minutes at room temperature (RT) 
and incubated with the primary Ab diluted in Ab diluent with 
background-reducing components for 60 minutes at RT. The 
sections were incubated for 30 minutes at RT with the link Ab; 
developed in 3-amino, 9 ethyl-carbazole substrate solution for 
10 minutes at RT; and counterstained with hematoxylin. A 
negative control experiment of each section was performed 
using the Ab diluent instead of the primary Ab. Intestinal 
tissue from gnotobiotic piglets experimentally infected with 
avian C psittaci strain T49/90 was used as a positive control 
sample.24
Serum Assay
For analysis of the serum samples, the recomLine Testkit 
Chlamydia (Mikrogen), a qualitative in vitro test for the detec-
tion of IgG and IgA-Abs against protein antigens of C tracho-
matis, C pneumoniae, and C psittaci, was used according to 
the manufacturer’s instructions.
Statistical Analyses
The distribution of C psittaci infection among nongas-
trointestinal and gastrointestinal MALT lymphomas, autoim-
mune precursor lesions, and nonneoplastic control samples 
was analyzed by using the !2 or Fisher exact test for categori-
cal variables. Analyses were carried out using SPSS software, 
version 15.0 (SPSS, Chicago, IL). All of the probability 
values were 2-sided, with an overall significance level of .05.
Results
C psittaci PCR, DNA Sequencing, and 
Immunohistochemical Studies
Of 47 nongastrointestinal MALT lymphomas 13 (28%) 
were positive for C psittaci DNA ❚Table 1❚. C psittaci was 
detected at variable frequencies in MALT lymphomas of dif-
ferent sites: 5 (100%) of 5 lung lymphomas (P < .01 compared 
with nonmalignant lung tissue); 3 (30%) of 10 thyroid gland 
lymphomas (P > .05 compared with nonmalignant thyroid 
gland); 2 (13%) of 15 salivary gland lymphomas (P > .05 
compared with nonmalignant salivary gland); 2 (15%) of 13 
ocular adnexal lymphomas; and 1 (25%) of 4 skin lympho-
mas. Together, nongastrointestinal MALT lymphomas were 
more frequently infected by C psittaci than their respective 
nonmalignant control specimens (lung, salivary, and thyroid 
gland, 4/30 [13%]; P = .139). Furthermore, 9 (56%) of 16 
specimens from patients with Sjögren syndrome and 2 (18%) 
of 11 specimens from patients with Hashimoto thyroiditis 
were positive for C psittaci DNA. In contrast, almost all 
21 gastrointestinal MALT lymphoma and control samples 
(including 14 MALT lymphomas of the gastrointestinal tract 
and 7 H pylori–positive gastritis samples) lacked detectable 
C psittaci DNA (Table 1). Comparing C psittaci infections of 
all nongastrointestinal MALT lymphomas to gastrointestinal 
MALT lymphomas revealed a detectable trend without reach-
ing statistical significance (P = .155). None of the MALT 
lymphoma specimens carried DNA for C trachomatis or C 
pneumoniae.
Positive results for 9 patients (8 with MALT lym-
phoma and 1 with Hashimoto thyroiditis) were confirmed 
by sequencing analysis of PCR products and confirmed 
the specificity of the amplified fragments. Moreover, these 
specimens displayed a marginal degree of sequence hetero-
geneity among different lymphoma cases, indicating infec-
tions by unrelated C psittaci variants and consequentially 
ruling out possible contamination from other sources ❚Figure 
1❚. By using immunohistochemical analysis, only 1 positive 
PCR result could be confirmed. A positive reaction was 
!Table 1!
Frequency of Chlamydia psittaci DNA Positivity by PCR in 
MALT Lymphomas, Nonmalignant Control Specimens, and 
Autoimmune Precursor Lesions
 No. of No. (%) 
Diagnosis/Organ Cases PCR+
Nongastrointestinal MALT lymphomas  
   Lung 5 5 (100)
   Thyroid gland 10 3 (30)
   Salivary gland 15 2 (13)
   Ocular adnexa 13 2 (15)
   Skin 4 1 (25)
   Total 47 13 (28)
Gastrointestinal MALT lymphomas  
   Stomach 6 0 (0)
   Intestine 8 1 (13)
   Total 14 1 (7)
Nonmalignant control specimens  
   Lung 10 0 (0)
   Thyroid gland 13 1 (8)
   Salivary gland 7 3 (43)
   Helicobacter pylori–positive gastritis 7 0 (0)
   Total 37 4 (11)
Autoimmune precursors  
   Hashimoto thyroiditis 11 2 (18)
   Sjögren syndrome 16 9 (56)
   Total 27 11 (41)
MALT, mucosa-associated lymphoid tissue; PCR, polymerase chain reaction.
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found mainly in macrophages surrounding the salivary duct 
system ❚Image 1❚.
Serum Assay
With the recomLine Chlamydia IgG test, 4 (29%) of 14 
serum samples from patients with nongastrointestinal MALT 
lymphomas analyzed tested positive for C trachomatis com-
pared with 18 (18%) of 100 control serum samples. For C 
pneumoniae, also 4 (29%) of 14 serum samples from patients 
with nongastrointestinal MALT lymphomas tested positive, in 
contrast with 60 (60%) of 100 control serum samples. For C 
psittaci, none of 14 serum samples from patients with nongas-
trointestinal MALT lymphomas were positive compared with 
1 (1%) of 100 in the control serum sample group.
Discussion
The concept that chronic inflammation due to infection 
by a pathogen such as H pylori, C jejuni, B burgdorferi, 
hepatitis C virus, or C psittaci or autoimmune disorders such 
as Sjögren syndrome and Hashimoto thyroiditis provides a 
staging ground for lymphocyte transformation and MALT 
lymphomagenesis has emerged in recent years. It has been 
suggested that the MZ B lymphocyte is the cell of origin 
that proliferates induced by a persisting antigen.3,7 Several 
antigens have been found responsible for chronic infection 
at various sites of MALT lymphoma origin. The outstanding 
response rate observed after microbial eradication therapy and 
the possibility of treating patients without antineoplastic 
CChlamydia psittaci
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❚Figure 1❚ Sequence alignment of polymerase chain reaction products from patients with mucosa-associated lymphoid tissue 
lymphomas (n = 8) and Hashimoto thyroiditis (n = 1). A dashed line indicates sequence identity of the patient with Chlamydia 
psittaci sequence; a letter indicates a different base; the prefix denotes the usual patient number. A, adenosine; C, cytosine; G, 
guanine; T, thymine.
A B
❚Image 1❚ A, Mucosa-associated lymphoid tissue (MALT) lymphoma of salivary gland. Immunohistochemical staining of 
Chlamydia psittaci. Overview of remnant of salivary duct with positive reaction in surrounding macrophages (Chlamydiaceae 
family–specific antibody, ×25). B, MALT lymphoma of salivary gland. Immunohistochemical staining of Chlamydia psittaci. Note 
positive reaction in macrophage (arrow) (Chlamydiaceae family–specific antibody, ×60).
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chemotherapy in a number of MALT lymphomas raises the 
need to further elucidate the as yet unrecognized microbial 
agents of MALT lymphomas at different sites of origin.8,13
In our study of 47 nongastrointestinal MALT lympho-
mas, 13 (28%) were positive for C psittaci DNA as opposed 
to 4 (11%) of 37 nonmalignant control specimens (P = .09; 
Table 1). These results are in accordance with a recent study 
by Ponzoni et al20 demonstrating an association between 
Chlamydia infection and lymphomas other than those aris-
ing from the ocular adnexa. By multiple detection methods, 
they elegantly identified the monocytic/macrophage system 
as a carrier of viable C psittaci. However, there were clear 
differences with our study regarding prevalence rates within 
the extranodal B-cell lymphoma subgroup: In contrast with 
Ponzoni et al,20 we found a 100% (5/5) positivity in MALT 
lymphomas of the lung and 2 of 15 (13%) of salivary gland 
lymphomas; C psittaci is an obligate intracellular bacterium 
that in humans causes pulmonary infections called psittaco-
sis. None of our normal lung specimens in our series (10/10) 
tested positive, indicating that C psittaci is not normally 
encountered at this localization.
A recent study of Chlamydia and Mycoplasma infections 
in pulmonary MALT lymphoma from 3 countries was also able 
to detect C psittaci in lung biopsy specimens, albeit at lower 
frequencies.25 Although we used identical PCR amplification 
methods, a further discrepancy with the findings of Ponzoni 
et al20 was a higher prevalence among ocular adnexal MALT 
lymphomas, with nearly 70% of cases testing positive com-
pared with 2 (15%) of 13 in the present study. Furthermore, 
we demonstrated 3 (30%) of 10 positive cases in thyroid gland 
MALT lymphomas, an entity that was not included in the 
study by Ponzoni et al.20 Methodological biases or geographic 
variation might account for these differences.26
Although it has been suggested that C pneumoniae and 
C trachomatis seropositivity may be associated with lym-
phomas,19 no evidence of infection with C pneumoniae and 
C trachomatis was found in our MALT lymphoma speci-
mens. Therefore, an association of MALT lymphomas and 
Chlamydia species other than C psittaci appears unlikely.
Immunohistochemically, only 1 positive PCR result 
could be confirmed. This might be due to different sensitivi-
ties of the applied methods or to imperfect antigen retrieval 
on the formalin-fixed, paraffin-embedded material. It is 
interesting that the positive reaction was exclusively found in 
macrophages, which have been shown by multiple detection 
methods to harbor viable and infectious C psittaci.8
Furthermore, no anti–C psittaci Abs were detected in 
14 serum samples from patients with nongastrointestinal 
MALT lymphomas. However, owing to a shortage of mate-
rial, the intratumoral C psittaci status of these patients is 
not known. In 100 control serum samples, 1 tested positive 
for C psittaci, reflecting the normal seroprevalence among 
the general population of the region not being exposed to 
chlamydial infections through work conditions. However, 
owing to the limited sensitivity and specificity of serologic 
test systems together with a high cross-reactivity for other 
chlamydial species, serologic testing is considered an unreli-
able method to predict associations of C psittaci infections 
and lymphomagenesis.
Among normal control tissue samples, 1 (8%) of 13 thy-
roid gland tissue specimens and 3 (43%) of 7 normal salivary 
gland tissue specimens also tested positive. Remarkably, 
in patients with Hashimoto thyroiditis (2/11 cases positive 
[18%]) and Sjögren syndrome (9/16 [56%]), 2 characteristic 
autoimmune precursor lesions of MALT lymphomas, an even 
higher infection rate of C psittaci was detected. Because sali-
vary and thyroid gland MALT lymphomas start as nonmalig-
nant antigen-selected expansion of polyclonal lymphoid cells 
with ongoing immunoglobulin gene hypermutation represent-
ing continuous antigen dependency, a potential role for C 
psittaci as an initiating pathogenetic event leading to chronic 
persisting inflammation may be hypothesized. By triggering 
a chronic antigen selection process, the bacterial infection 
may initiate an autoimmune response and finally promote 
lymphomagenesis.
Virtually no gastrointestinal MALT lymphoma or H 
pylori–positive gastritis specimens tested positive for C psitta-
ci DNA, corroborating findings of H pylori and C jejuni being 
the dominant causative microorganisms of MALT lymphoma 
development in these anatomic regions.
These findings suggest a possible role for C psittaci in 
MALT lymphomagenesis at nongastrointestinal sites beyond 
the ocular adnexa with potential clinical implications for 
antibiotic treatment: Recent reports provide encouraging data 
about long-lasting clinical remissions of C psittaci–positive 
ocular adnexal MALT lymphomas induced by doxycycline 
used as first-line treatment, even in patients with multiple 
failures with previous chemotherapy or radiotherapy.13,14 
There is also sporadic evidence of therapeutic success in a 
case of C psittaci–positive diffuse large B-cell lymphoma of 
the bronchus27 and of transformed high-grade gastric MALT 
lymphomas treated with antibiotics alone.28 In marked con-
trast, ex juvantibus doxycycline treatment in patients with 
MALT lymphoma of the ocular adnexa without prior testing 
for C psittaci DNA did not result in any significant response 
and was considered ineffective.29 Hence, exclusive antibiotic 
treatment in C psittaci–positive patients remains an investiga-
tional approach and must be carefully evaluated in prospec-
tive randomized trials.
This study demonstrated the presence of C psittaci 
DNA in a larger cohort of nongastrointestinal MALT 
lymphomas other than ocular adnexa. Furthermore, a high 
prevalence of C psittaci infection in patients with Sjögren 
syndrome and Hashimoto thyroiditis, 2 frequent precursor 
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lesions for MALT lymphomas, suggests possible involvement 
of C psittaci–induced antigenic-driven MALT lympho-
magenesis. However, the pathophysiologic and clinical 
implications deserve further investigation.
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